Scientists develop a 10-second HIV test linked to mobile phones

September 28, 2017, University of Surrey
HIV infecting a human cell. Credit: NIH

The University of Surrey, working with colleagues at University College London, the Africa Health research Institute (South Africa), OJ-Bio (Newcastle), QV (holdings (Netherlands) and the Japan Radio Co Ltd, have developed a mobile test using technology found in smartphones, and it could provide doctors and carers with a virtually instantaneous way of diagnosing someone with HIV. The test uses just a single drop of blood from a patient to produce a positive test within 10 seconds.

The test, announced in Scientific Reports, uses surface acoustic wave (SAW) biochips, which are based on microelectronic components found in smartphones. The disposable quartz biochips are extremely fast because they do not require complex labelling, amplification or wash steps, and a pocket-sized control box reads out the SAW signal and displays results electronically.

Early detection of HIV is vital to help contain potential outbreaks, but existing tests require complex analysis equipment and long waiting times for results.

The team first optimized SAW biochips and capture coatings to detect model HIV antibodies and recombinant antigens (anti-p24 and p24 respectively) exploiting small llama antibody technology. This was then used to test real patient samples, using differential measurements, in order to achieve high specificity and sensitivity within seconds.

The research opens up the potential of consumer electronics to cut lengthy test waiting times, giving patients on the spot access to potentially life-saving treatment and supporting more timely to prevent disease outbreaks.

Professor Vince Emery, Senior Vice-President (Global Strategy and Engagement) and Professor of Translational Virology at the University of Surrey, said: "This research shows that we can find the perfect marriage between traditional medical science and cutting edge mobile technology to make a real difference to diagnosing serious viruses within seconds. The development is a great example of how multidisciplinary research, supported through the NIHR and the EPSRC interdisciplinary research centre, i-sense, can lead to technological breakthroughs that impact on global health.

"We have developed this 10-second for HIV using existing smartphone technology, but it could in theory be used for a range of viruses, such as Zika or Ebola, potentially meaning that we can identify serious outbreaks before they become full epidemics, especially if we can link it with the evolving 5G technologies in the future."

Early diagnosis and access to antiretroviral treatment increases life-expectancy by 10 years, reduces infant mortality by 76% and in pregnant women can almost completely prevent transmission to their baby.

Professor of Biomedical Nanotechnology at UCL and Director of i-sense, Professor Rachel McKendry, said: "This is an exciting breakthrough that lays the foundations for future clinical studies and product development.

"If successful, this platform technology could revolutionalise rapid HIV diagnosis and deliver major health and economic benefit to millions of people worldwide."

CEO of OJ-Bio, Dr Dale Athey, explains, "Current point-of-care tests for HIV based on lateral flow are still relatively slow, with most between 10-20 minutes to produce results, which exceeds the approximate nine minutes for a doctor's appointment in the UK."

"The 10-second result time achieved here makes this approach a potential game changer."

Explore further: Rapid, easy Zika test developed

More information: Valérian Turbé et al, Towards an ultra-rapid smartphone- connected test for infectious diseases, Scientific Reports (2017). DOI: 10.1038/s41598-017-11887-6

Related Stories

Rapid, easy Zika test developed

September 27, 2017
A new fast, easy and cheap "dipstick" test for the Zika and dengue viruses could revolutionize public health response to dangerous tropical germs, a new study reports.

Saliva as good as blood for diagnosing hepatitis E, study suggests

July 19, 2017
A saliva test developed by researchers at the Johns Hopkins Bloomberg School of Public Health nearly matches the performance of a blood test widely used to assess recent or past hepatitis E virus (HEV) infection, a new study ...

Printable tool enables sensitive diagnostic testing

August 7, 2017
Biomedical engineers at Duke University have created a portable diagnostic tool that can detect telltale markers of disease as accurately as the most sensitive tests on the market, while cutting the wait time for results ...

Research uncovers life-saving benefits in the battle against viruses

April 20, 2017
At-risk patients, such as those with HIV or transplant recipients, could benefit from potentially life-saving study carried out by a University of Surrey led group of international researchers.

Recommended for you

Study shows how MERS coronavirus evolves to infect different species

August 14, 2018
In the past 15 years, two outbreaks of severe respiratory disease were caused by coronaviruses transmitted from animals to humans. In 2003, SARS-CoV (severe acute respiratory syndrome coronavirus) spread from civets to infect ...

Inching closer to a soft spot in isoniazid-resistant tuberculosis

August 14, 2018
Antibiotic-resistant tuberculosis is a public health threat. TB and other bacteria become resistant to antibiotics by evolving genetic changes over time, which they can do quite quickly because bacterial lifecycles are short. ...

How long is an Ebola survivor contagious? One case is causing scientists to rethink the answer.

August 14, 2018
Surviving Ebola isn't like getting over the flu.

Why do women get more migraines?

August 14, 2018
Research published today reveals a potential mechanism for migraine causation which could explain why women get more migraines than men. The study, in Frontiers in Molecular Biosciences, suggests that sex hormones affect ...

Link between common 'harmless' virus and cardiovascular damage

August 13, 2018
Researchers from Brighton and Sussex Medical School (BSMS) have found an unexpectedly close link between a herpes virus and the occurrence of immune cells damaging cardiovascular tissue.

Rotavirus vaccine cuts infant diarrhoea deaths by a third in Malawi

August 11, 2018
A major new study has shown that rotavirus vaccination reduced infant diarrhoea deaths by 34% in rural Malawi, a region with high levels of child deaths.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.